Using Aroma to Optimize Your Ketamine Session: The Science of Set, Setting, and Smell

May 5, 2026Science of Ketamine· Reviewed by Mai Shimada, MD

Aroma and ketamine therapy: how scent supports set, setting, and integration

When patients prepare for a ketamine session, they tend to optimize the obvious things: a comfortable space, an eye mask, a curated playlist, an intention to hold. Almost no one thinks about what they're going to smell.

That's a meaningful gap. Of every sensory input in the room, scent has the most direct biological line to the structures ketamine is acting on. A scent doesn't ask permission. It bypasses the relay every other sense has to pass through and lands — within milliseconds — in the amygdala, hippocampus, and orbitofrontal cortex. Those are precisely the regions most engaged by what makes ketamine therapeutic: emotional reappraisal, memory reconsolidation, and the way the brain weights threat and meaning.

This piece is about why scent deserves a place on the set-and-setting checklist, and how to use it deliberately.

Why smell has the most direct line to your brain

Most of what you sense never reaches your cortex directly. Sight, sound, touch, taste — all of it routes through the thalamus first, a kind of central switchboard that filters and forwards before primary cortical processing. Olfaction is the exception. Odor molecules bind to receptors in the nasal epithelium, signal the olfactory bulb, and from there project monosynaptically — across a single synapse — to the primary olfactory cortex, which includes the piriform cortex, anterior olfactory nucleus, olfactory tubercle, and several subregions of the amygdala (Zhou et al., 2025).

That single piece of anatomy explains a lot. It's why a particular scent can pull up a vivid emotional memory faster than you can say what the smell is: the limbic and mnemonic structures see it before the parts of your brain that label and describe.

The downstream targets matter for ketamine work specifically. The amygdala shapes how you appraise threat and salience. The hippocampus binds together the episodic, contextual fabric of an experience — what happened, where, in what order. The orbitofrontal cortex, which receives heavy olfactory input, is where value, reward, and emotional meaning get integrated (Zhou et al., 2019). These are not incidental regions. They are the same circuits implicated in the depressive, anxious, and trauma-related patterns ketamine is being used to soften.

Ketamine's therapeutic window is, in part, a window of heightened plasticity in those circuits. A scent introduced into the session isn't a passive backdrop — it's an input arriving on a fast lane to the very structures the medicine is loosening.

What aroma actually does

Mood

The strongest mood-state evidence in clinical settings comes from bergamot. In a pilot study run inside the waiting room of an outpatient mental-health treatment center, fifteen minutes of ambient bergamot inhalation produced a measurable lift in self-rated positive feelings compared to no-aroma controls — in a real clinical environment, not a laboratory mood-induction setup (Han et al., 2017). A separate randomized controlled trial in postpartum women found that ten minutes of daily bergamot inhalation over two weeks produced significant improvements in depressive mood and sleep quality versus a control condition (Chen et al., 2022).

The plausible mechanism isn't mysterious. In a controlled study of healthy adult women, bergamot inhalation was associated with simultaneous increases in self-reported positive mood, increased parasympathetic nervous system activity, and decreased salivary cortisol within fifteen minutes (Watanabe et al., 2015). That triangulation — subjective state, autonomic tone, and a stress hormone all moving in the same direction — is more convincing than any one of those signals alone.

Sweet orange and lemon oils show similar but less-replicated patterns, mostly in healthy-volunteer mood-induction designs. They're reasonable choices, but the evidence base is thinner than for bergamot.

A few honest caveats:

These are mood-state effects, on the order of fifteen to thirty minutes — not treatments for clinical depression. Bergamot is not a substitute for ketamine, an SSRI, or therapy.
Effect sizes in inhalation aromatherapy studies are typically modest. The signal is real and replicated, but no one should expect a transformation from a citrus diffuser.
Most studies are short-duration and use heterogeneous methodologies (different concentrations, delivery devices, exposure times). Cross-study comparison is rough.

For ketamine work specifically, the value isn't that bergamot replaces anything. It's that a low-cost, low-risk intervention can shift baseline mood and autonomic tone in a favorable direction during the minutes leading into a session — exactly when set matters most.

Anxiety

Lavender has the largest evidence base of any aromatic compound for anxiety, but the picture comes with an important asterisk: most of the strongest data is for oral lavender oil capsules — specifically a standardized preparation called Silexan — not for inhaled aromatherapy.

In a 10-week double-blind RCT of patients with generalized anxiety disorder, Silexan 80 mg/day was significantly superior to placebo and showed comparable efficacy to paroxetine 20 mg/day on the Hamilton Anxiety Rating Scale, with a more favorable adverse-event profile than the SSRI comparator (Kasper et al., 2014). A 2023 meta-analysis pooling five RCTs (n=1,213) confirmed a significant reduction in HAMA total, psychic, and somatic subscores versus placebo (Dold et al., 2023). The active constituents — primarily linalool and linalyl acetate — cross the blood-brain barrier and act as voltage-dependent calcium channel modulators in central neurons. So when people say "lavender works for anxiety," they're often citing pharmacology that looks more like an oral medication than what most patients picture when they hear "aromatherapy."

Inhaled lavender has weaker but still real evidence, mostly in pre-procedural anxiety contexts (dental, surgical, ICU). A 2019 systematic review of inhalation studies found a generally consistent anxiolytic signal across heterogeneous designs, though effect sizes were smaller and more variable than for oral preparations (Donelli et al., 2019). Bergamot inhalation has shown reductions in pre-operative anxiety and is plausibly useful in the same pre-session window.

Where this approach is not appropriate:

Active panic or trauma activation. A novel scent introduced during a panic state can become a learned threat cue. If a patient is already in distress, the priority is grounding, not new sensory input.
Strong existing scent associations. Smells linked to a past trauma, a hospital, a deceased loved one — these will dominate any intended effect.
Asthma or scent sensitivity. Always patient-led.

For ketamine sessions, the practical play is anxiolytic scent in the pre-dosing window, used to lower baseline arousal — not as a rescue tool mid-session.

Cognition and focus

The cognition findings come from a smaller but cleaner literature, dominated by work from Mark Moss and colleagues on rosemary.

In a 2012 study, twenty healthy adults performed serial-subtraction and visual-information-processing tasks in a cubicle diffused with rosemary essential oil. The researchers measured plasma concentrations of 1,8-cineole — the primary volatile compound in rosemary that is absorbed through the nasal mucosa and crosses into systemic circulation — and found that higher plasma concentrations correlated with better performance on tasks demanding working memory (Moss & Oliver, 2012). The mechanism is plausible: 1,8-cineole inhibits acetylcholinesterase, slowing the breakdown of acetylcholine, which is the same pharmacological lever pulled by the cholinesterase inhibitors used in early Alzheimer's disease.

Subsequent work by the same group extended the finding to prospective memory — remembering to do something at a future cue — and to specific subtests of secondary memory in older adults. Peppermint shows a related pattern for alertness and reaction-time tasks, though the literature is thinner.

A few framings for the ketamine context:

These cognitive effects are not what you want during a dosing session. Working-memory enhancement is the wrong tool when the goal is to soften analytic guarding and let material surface.
They are useful in the integration window — the days between sessions when patients journal, work with their therapist, and try to consolidate insights into behavior.
A rosemary scent paired with journaling or integration sessions is a low-cost way to support exactly the kind of cognitive work that turns a session into change.

Brain changes — and the limits of the claim

This is the section most worth getting right. The popular framing — "smell rewires your brain" — overstates what the evidence shows. The careful framing is more interesting anyway.

What's been demonstrated:

In a 6-week study of healthy young adults, a structured olfactory training protocol (multiple daily exposures to a curated set of odors with discrimination and identification tasks) produced measurable increases in cortical thickness in the entorhinal cortex, fusiform gyrus, and inferior frontal gyrus on MRI (Al Aïn et al., 2019). These are olfactory-relevant regions; the changes were not whole-brain.
In patients with idiopathic olfactory loss, twelve weeks of structured olfactory training improved odor identification and produced regional gray-matter volume increases in olfactory processing regions (Han et al., 2021).
Most striking: in a 2023 trial, older adults aged 60–85 who used an overnight diffuser cycling through seven different odors over six months showed a 226% improvement on the Rey Auditory Verbal Learning Test compared to controls, alongside changes in the uncinate fasciculus — the white-matter tract connecting orbitofrontal cortex to the medial temporal lobe (Woo et al., 2023).

What's not been demonstrated:

That a single ketamine session paired with a scent produces structural change.
That casual, occasional diffuser use rises to the threshold of training. Effect sizes track with consistency and exposure time.
That aromatherapy added to ketamine treatment improves outcomes versus ketamine alone — that trial hasn't been run.

The honest claim is this: the olfactory system is one of the most reliably plastic systems in the adult human brain, and consistent olfactory engagement appears to support — not replace — the kind of plasticity ketamine is also recruiting. Aroma is one input among many. Treat it that way.

Three ways to use aroma in your ketamine treatment

The science above gets concrete in three places. Each one corresponds to a different phase of treatment and a different goal.

Pre-session priming

The fifteen to thirty minutes before dosing are when arousal matters most. Patients who arrive tense spend the first part of a session settling rather than working. An anxiolytic scent — bergamot or inhaled lavender — introduced during this window can compress that settling time. The mechanism is the one the bergamot literature consistently shows: a small, fast shift in autonomic tone (parasympathetic up, cortisol down), reflected in subjective calm.

A rule worth holding: don't introduce a brand-new scent at the moment of dosing. The pre-session period is for grounding, not novelty. Save novelty for the next use case.

In-session anchoring

This is the most under-used application, and it's straightforward classical conditioning. Pair a single, deliberately chosen scent with the dosing experience itself — present from the moment the medicine is taken, sustained throughout the session.

Two design choices matter. First, the scent should be novel to the patient — not their morning coffee, not a familiar candle, not anything tied to a strong existing memory. Novelty gives you a clean substrate; the scent gets associated with the state of the session and little else. Second, use the same scent every session. Reinforcement is what builds the anchor.

What you get is a state-dependent retrieval cue. Re-introducing that scent later — during a difficult moment, before a hard conversation, in a journaling session — pulls along some of the affective texture of the dosing experience itself. Patients describe it as a way to "borrow back" the equanimity or perspective they accessed during a session. The neuroanatomy above is what makes this work: the scent has direct access to the same limbic structures that encoded the original state.

Between-session regulation

The same anchored scent then becomes a portable tool during integration. It pairs naturally with practices Isha already supports — journaling, guided imagery, breathwork — and gives patients a tangible cue to bring back the work of a session into a moment when they need it.

If a patient also wants a separate cognitive aid for journaling — rosemary, peppermint — that's reasonable, but keep it distinct from the anchor scent. Mixing roles muddies the conditioning. One scent for state, one for sharpness.

The whole approach is low-cost, low-risk, and built on a mechanism that's been studied for decades in non-aroma contexts. Aroma is just an unusually clean delivery vehicle for it.

A practical guide

Delivery method

Three formats, each with tradeoffs:

Diffuser. Ambient, passive, fills a room. Best for pre-session priming and overnight use. Lower precision — once the room is scented, you can't easily back off.
Personal inhaler / aroma stick. A small wick saturated with essential oil, held under the nose. Portable, precise, and the format with the most evidence behind it for in-session and on-demand use. Recommended for the in-session anchor and for between-session use.
Roll-on or skin application. Long exposure, but proximity matters and skin reactions are more common. Avoid citrus oils on skin before sun exposure (see safety, below).

Dosing

Less is more. Strong scent during a ketamine session can become aversive — the dissociative state amplifies sensory input rather than dampening it. Start lower than you think you need. A few drops on a wick or a brief, intermittent diffuser cycle is usually enough. If the scent is the loudest thing in the room, it's too loud.

Picking your scent

For an anchor scent, novelty matters more than the specific oil. What you want is something that doesn't already pull up associations. Personal blends — combinations of two or three oils mixed yourself — work well precisely because no one else's bottle smells exactly the same. Avoid scents tied to a deceased loved one, a hospital, or a difficult relationship; those associations will dominate any intended effect.

Safety

A few non-negotiables:

Pets. Many essential oils — tea tree, eucalyptus, certain citrus oils at high concentration — are toxic to cats and dogs. If pets share your space, research each oil first.
Asthma and scent sensitivity. Strong aromatics can trigger bronchospasm. Test outside a session first.
Pregnancy. Several oils are contraindicated; check with your clinician before adding any during pregnancy.
Photosensitivity. Bergamot, lemon, lime, and other citrus oils on the skin can cause UV reactions for hours afterward. Stick to inhalation for these.

What we still don't know

The honest summary of the evidence is this: we have good data on aroma and mood, on aroma and anxiety, on aroma and cognition, and on the brain's structural responsiveness to consistent olfactory engagement. We do not have a randomized trial of aromatherapy combined with ketamine treatment. That trial hasn't been run.

Almost everything we know about scent in clinical contexts comes from adjacent populations — pre-surgical anxiety, postpartum depression, generalized anxiety disorder, dementia care, healthy-volunteer cognition studies. Extrapolating to ketamine work is reasonable, but it is extrapolation.

Effect sizes for inhalation aromatherapy are also generally modest. The signal is consistent and replicated, but it is not the size of an SSRI or a course of ketamine — it is the size of one well-chosen tool added to a stack.

The right framing is conservative: aroma is plausibly helpful and low-risk, not a proven protocol. Use it that way.

Bringing it together

The thread running through everything Isha publishes about set and setting is the same: a ketamine session is not just the medicine. It is the medicine and the conditions you build around it. Lighting, music, intention, the people in the room, the way you prepare, the way you integrate — all of it shapes what the session becomes.

Scent belongs on that list. The biology is unusually direct, the cost is low, and the risks are small for most patients. If you're preparing for a session, talk to your clinician about adding an aroma component to your set-and-setting plan — and consider working through our pre-session checklist as a starting point.

References:

Considering ketamine therapy? Isha Health offers physician-led at-home treatment with an 88.8% improvement rate. Check appointment availability.

88.8% of Isha Health patients with moderate-to-severe depression show measurable improvement

Based on 546 patients and 1,900+ validated assessments. See our clinical outcomes →

Neuroplasticity window after ketamine therapy practical guide

The Neuroplasticity Window: What to Do After Ketamine

Ketamine triggers a 24-72 hour neuroplasticity window through BDNF release. Here is a practical guid...

How Psychedelics Transform Music Perception and Emotional Processing

Discover how psychedelics enhance music perception and emotional processing, deepening connections,...

How Fish Reacting to Ketamine May Unlock New Treatments for Depression

Discover how zebrafish are helping researchers uncover the rapid-acting antidepressant effects of ke...